Portfolio company
Contraline
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
About
This biotechnology company develops long-lasting, reversible male contraceptive products, including injectable hydrogels and hormonal gels, for men and couples.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
YourChoice Therapeutics
This company develops hormone-free, oral contraceptive pills for men and women to provide reversible and safe family planning options.
Plan A
This company develops long-lasting, non-hormonal and reversible male contraceptive products for the consumer health market.
June Livia
This company develops a wearable in-body sensor and mobile application providing continuous reproductive health data for women seeking hormone-free contraception and fertility insights.
FertereX
This company develops a photobiomodulation therapy device designed to improve sperm quality and testosterone levels for men experiencing fertility issues.
Rejoni
This company develops hydrogel systems to prevent intrauterine adhesions and improve healing in women undergoing gynaecological surgery.
Calla Lily Clinical Care
This company develops a leak-free vaginal drug delivery platform for women requiring fertility treatments, miscarriage management, and other gynaecological medications.
Paterna Biosciences
Paterna Biosciences develops in vitro spermatogenesis technology to produce functional sperm from stem cells for clinics treating male infertility.
Sebela Pharmaceuticals
This company develops gastrointestinal medicines and women's health products, including contraceptives, for patients and healthcare providers.
